A Risk Sciences International news item posted on November 4, 2025 and last updated on November 4, 2025

IARC recently published a volume on quantitative bias modelling: Bias assessment in case–control and cohort studies for hazard identification (IARC Scientific Publication No. 171). We are pleased to see inclusion of some of the work RSI’s Drs Franco Momoli and Daniel Krewski conducted for the INTERPHONE and MOBI-Kids studies of cell phones, radiofrequencies, and brain tumours as examples in the text. The IARC publication includes several fantastic resources that epidemiologists can add to their statistical armamentarium. This entails using data external to the study to address unmeasured confounders, measurement error on variables, and issues arising from selection into and out of study populations.

These methods, while still not widely adopted, are found in several modern epidemiologic textbooks, and they deserve wider appreciation. Recommendations have been made to use quantitative bias methods to more transparently discuss study limitations, to understand the robustness of study results during journal peer review, and to properly characterize sources of systematic bias in regulatory contexts. The first step is often planning for this work at the grant funding stage.

Work conducted by Risk Sciences International for Health Canada has also involved these approaches with benchmark dose modelling leading to deriving health-based regulatory values for drinking water and air quality. These methods typically use high quality key epidemiologic studies that, nevertheless, had limitations that deserve quantitative characterization of uncertainty.

Experts related to this news item

Franco Momoli

Vice-President Chemical and Product Safety

Dr. Franco Momoli joined Risk Sciences International (RSI) in 2019 and currently serves as Vice-President, Chemical and Product Safety. In this role, he leads a multidisciplinary team of epidemiologists, risk assessors, toxicologists, and biostatisticians in conducting human health risk assessments...
Read More about Franco Momoli

Daniel Krewski

Chief Risk Scientist

Dr. Daniel Krewski is Chief Risk Scientist and co-founder of Risk Sciences International (RSI), a firm established in 2006 to bring evidence-based, multidisciplinary expertise to the challenge of understanding, managing, and communicating risk. As RSI’s inaugural CEO and long-time scientific...
Read More about Daniel Krewski

More RSI News

RSI launches Global Risk Census

March 1, 2022

Risk Sciences International has launched The Global Risk Census. The goal of the Census is to provide insights into important risks that need to be…

Read News Item

US FDA FAERS and quinolones

June 22, 2021

Some case reports on Quinolones, a potent and globally popular group of antibiotics that are used to treat a wide range of infections, have raised…

Read News Item

Cell phones and cancer

May 26, 2021

Drs. Daniel Krewski and Franco Momoli recently contributed to an environmental research paper entitled: Cell phone use and the risk of glioma: are case-control study…

Read News Item

Advancing Toxicity Testing webinar

May 25, 2021

The Center for Alternatives to Animal Testing and the Animal-Free Safety Assessment recently held their annual meeting on advancing toxicity testing in the 21st century…

Read News Item